Results 111 to 120 of about 2,353 (181)

Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China

Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China
2000 【要旨】 Offprint. Originally published in; Epidemiology infection, v.
openaire  

Drug resistance profile of <i>Mycobacterium tuberculosis</i> in China: update until 2024. [PDF]

Front Microbiol
Xu Y, Liu S, Zheng J, Lin J, Gi L, Chang Q.   +5 more
europepmc   +1 more source

Editorial: Insights in aging, metabolism and redox biology: 2024. [PDF]

Front Aging
Dagda RK, Zhang J.
europepmc   +1 more source

Genetic Analysis of Molecular Mechanisms of Drug Resistance in <i>Mycobacterium tuberculosis</i> Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide). [PDF]

Infect Drug Resist
Roshdi Maleki M.
europepmc   +1 more source

Characterization of Drug Resistance Mutations in <i>Mycobacterium tuberculosis</i> Isolates from Moroccan Patients Using Deeplex Targeted Next-Generation Sequencing. [PDF]

Microorganisms
Laatri S, El Kassimi S, Bentaleb EM, El Messaoudi MD, Irobi J, Belkadi B, Filali-Maltouf A, Ait Benhassou H.   +7 more
europepmc   +1 more source

Tissue-specific effects of bacterial PncA overexpression on NAD⁺ metabolism and aging in mice: implications for tissue-specific aging interventions. [PDF]

Front Aging
Huo F, Zhao M, Liu Y, Lv S, Feng S, Guo L, Wang N, Zhang S, Liu Q, Mi T, Wang H, Zhu JK, Liu H.   +12 more
europepmc   +1 more source

The Identification of Novel Mutations in ATP-Dependent Protease ClpC1 Assists in the Molecular Diagnosis of Obscured Pyrazinamide-Resistant Tuberculosis Clinical Isolates. [PDF]

Microorganisms
Hameed HMA, Fang C, Liu Z, Gao Y, Wang S, Chen X, Zhong N, Aung HL, Hu J, Zhang T.   +9 more
europepmc   +1 more source

Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). [PDF]

BMC Infect Dis
Castello FA, Sosa EJ, Campos J, Monteserin J, Poklepovich T, Palumbo MC, Serral F, Messano J, García LG, Simboli N, Turjanski A, Paul R, López B, Matteo M, Palomino MM, Martí M, Fernández Do Porto D.   +16 more
europepmc   +1 more source

Resistance mutations – this table provides a catologue of high-level resistance conferring mutations to other anti-TB drugs we detected i.e., in the katG gene (isoniazid resistance), pncA gene (pyrazinamide resistance) and rrs gene (kanamycin resistance).

David Patrick Kateete (8446950), Shakira Namakula (22784101), Edgar Kigozi (724127), Fred A. Katabazi (22784104), George William Kasule (10803282), Kenneth Musisi (440368), Edward Wampande (3495746), Deus Lukoye (357718), Moses L. Joloba (7122824)   +8 more
openalex   +1 more source

<i>In silico</i> analysis of the functional implications of drug resistance associated mutations in <i>Mycobacterium tuberculosis</i>. [PDF]

Comput Struct Biotechnol J
Pal A, Pal S, Mahapatra S, Pandey A, Mohanty D.   +4 more
europepmc   +1 more source